Register to get free articles
Want unlimited access? View Plans
Already have an account? Sign in
Hazlewoods healthcare team has been named a finalist in the Corporate Financier of the Year category of HealthInvestor’s annual Awards.
The healthcare sector specialism within the Hazlewoods Corporate Finance team, inclusive of health and social care, dental, veterinary, and pharmacy, saw a 23% uplift on deal volume compared to 2023, having completed 73 deals worth £754m in 2024.
Made up of acquisitions, disposals, financing/refinancing, and sale and leasebacks, deal values have ranged as high as £150m. The team have worked with many of the key investors in the health and social care sector, including Bupa Occupational Health, Lexxic, Ignite, Shawbrook, Kin Vet, and Optimo Care Group to name just a few.
With a reputation established in the UK healthcare market, Hazlewoods Healthcare team’s sub sector focus has grown substantially over the past 30 years, spanning across elderly care homes, children’s residential care, supported living, domiciliary care, SEND, day nurseries, fostering, dentistry, pharmaceuticals, veterinary, white coat medical services, and care technology.
The HealthInvestor Awards have been recognising and celebrating the best in this industry for nearly 20 years, across categories including advisory and finance, clinical services, property, and more.
Richard Dade, Hazlewoods partner, said: “To be named finalists highlights our dedication and expert delivery over the past 12-months, as we continue to forge opportunities, strengthen our network, and achieve the very best outcomes for our clients in the health and social care sector.”
John Lucas, Hazlewoods partner, added: “2024 was a strong year for us, which we’re building on into this year’s first quarter and later into 2025 with many mandates expected to come to market in the near future. There is a strong appetite for transactions across the sector, with a peaked interest in exit routes that are considering all options, including EOTs, and sales to trade and private equity investors.”
